BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16337504)

  • 1. Short- and long-term influence of diet and simvastatin on brachial artery endothelial function.
    Jensen LO; Thayssen P; Pedersen KE; Haghfelt T
    Int J Cardiol; 2006 Feb; 107(1):101-6. PubMed ID: 16337504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular effects of diet and statin in hypercholesterolemic patients.
    Koh KK; Son JW; Ahn JY; Jin DK; Kim HS; Choi YM; Ahn TH; Kim DS; Shin EK
    Int J Cardiol; 2004 Jun; 95(2-3):185-91. PubMed ID: 15193818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of endothelial dysfunction with simvastatin in patients with autosomal dominant polycystic kidney disease.
    Namli S; Oflaz H; Turgut F; Alisir S; Tufan F; Ucar A; Mercanoglu F; Ecder T
    Ren Fail; 2007; 29(1):55-9. PubMed ID: 17365910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of myocardial ischemia with simvastatin in addition to conventional treatment in patients with chronic coronary artery disease.
    Verri V; Cunha AB; Tessarolo LE; Carneiro RC; Romêo Filho LJ
    Rev Port Cardiol; 2004 Sep; 23(9):1089-105. PubMed ID: 15587571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of simvastatin on pro-inflammatory cytokines in patients with hypercholesterolemia.
    Zubelewicz-Szkodzińska B; Szkodziński J; Danikiewicz A; Romanowski W; Błazelonis A; Muc-Wierzgon M; Pietka-Rzycka A; Muryn Z
    Kardiol Pol; 2003 Dec; 59(12):465-74. PubMed ID: 14724693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of simvastatin on endothelial function in cardiac syndrome X patients.
    Fábián E; Varga A; Picano E; Vajo Z; Rónaszéki A; Csanády M
    Am J Cardiol; 2004 Sep; 94(5):652-5. PubMed ID: 15342302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
    Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
    Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):182-8. PubMed ID: 17399968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
    Borghi C; Dormi A; Veronesi M; Sangiorgi Z; Gaddi A;
    Am Heart J; 2004 Aug; 148(2):285-92. PubMed ID: 15308998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.
    Settergren M; Böhm F; Rydén L; Pernow J
    Eur Heart J; 2008 Jul; 29(14):1753-60. PubMed ID: 18441323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot study.
    Grodzińska L; Starzyk D; Bieroń K; Goszcz A; Korbut R
    Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):413-9. PubMed ID: 15910404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy.
    Lima JA; Desai MY; Steen H; Warren WP; Gautam S; Lai S
    Circulation; 2004 Oct; 110(16):2336-41. PubMed ID: 15477398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
    Fox KM; Gandhi SK; Ohsfeldt RL; Davidson MH
    Am J Manag Care; 2007 Dec; 13 Suppl 10():S270-5. PubMed ID: 18095777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function.
    Pirro M; Schillaci G; Romagno PF; Mannarino MR; Bagaglia F; Razzi R; Pasqualini L; Vaudo G; Mannarino E
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):14-21. PubMed ID: 19158317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary intervention and lipid-lowering treatment on brachial vasoreactivity in patients with ischemic heart disease and hypercholesterolemia.
    Søndergaard E; Møller JE; Egstrup K
    Am Heart J; 2003 May; 145(5):E19. PubMed ID: 12766751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.